Hemophilia B

The FDA has expanded the use of Opdivo (nivolumab) for the treatment of patients with urothelial carcinoma, the most common form of bladder cancer.

The FDA approved Symbicort Inhalation Aerosol 80/4.5 for the treatment for the treatment of asthma in pediatric patients aged 6 to 12 years.

The FDA approved Symbicort Inhalation Aerosol 80/4.5 for the treatment for the treatment of asthma in pediatric patients aged 6 to 12 years.

The FDA approved Symbicort Inhalation Aerosol 80/4.5 for the treatment for the treatment of asthma in pediatric patients aged 6 to 12 years.

The FDA has approved AirDuo RespiClick and ArmonAir RespiClick for the treatment of adolescent and adult patients with asthma.

The FDA has approved AirDuo RespiClick and ArmonAir RespiClick for the treatment of adolescent and adult patients with asthma.

The FDA has approved AirDuo RespiClick and ArmonAir RespiClick for the treatment of adolescent and adult patients with asthma.

The FDA has approved Trulance (plecanatide) for the treatment of chronic idiopathic constipation in adults.

The FDA has approved Trulance (plecanatide) for the treatment of chronic idiopathic constipation in adults.

The FDA has approved Trulance (plecanatide) for the treatment of chronic idiopathic constipation in adults.